CID is 6047
synonyms found at PubChem are:
levodopa, L-dopa, 59-92-7, Dopar, 3,4-dihydroxy-L-phenylalanine, 3-Hydroxy-L-tyrosine, Larodopa, Bendopa, Levopa, Cidandopa, Insulamina, Maipedopa, Dopaidan, Dopalina, Dopasol, Eldopal, Eldopar, Pardopa, Prodopa, Syndopa, (-)-Dopa, Dihydroxy-L-phenylalanine, Helfo-Dopa, Brocadopa, Dopaflex, Deadopa, Dopal-fher, 3,4-Dihydroxyphenylalanine, 3-(3,4-Dihydroxyphenyl)-L-alanine, Doparkine, Dopaston, Dopastral, Eldopatec, Eurodopa, Doparl, Doprin, Veldopa, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, Levedopa, Levodopum, L-o-Hydroxytyrosine, Dopa, Ledopa, (-)-3-(3,4-Dihydroxyphenyl)-L-alanine, L-3,4-Dihydroxyphenylalanine, L-Tyrosine, 3-hydroxy-, 3,4-Dihydroxyphenyl-L-alanine, Dopaston SE, beta-(3,4-Dihydroxyphenyl)-L-alanine, L-(o-Dihydroxyphenyl)alanine, L-(-)-Dopa, L-beta-(3,4-Dihydroxyphenyl)alanine, Biodopa, Cerepap, Sobiodopa, Weldopa, Parda, L-Dihydroxyphenylalanine, Helfo DOPA, Ro 4-6316, beta-(3,4-Dihydroxyphenyl)alanine, L-3-Hydroxytyrosine, L-3-(3,4-Dihydroxyphenyl)alanine, Tyrosine, 3-hydroxy-, Laradopa, Levodopum [INN-Latin], L-O-Dihydroxyphenylalanine, alanine, 3-(3,4-dihydroxyphenyl)-, L-, component of Sinemet, CCRIS 3766, Dopar (TN), (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, CHEBI:15765, HSDB 3348, beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine, L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine, UNII-46627O600J, 3,4-Dihydroxyphenylalanine (VAN), Alanine, 3-(3,4-dihydroxyphenyl)-, (-)-, L(-)-Dopa, (-)-(3,4-Dihydroxyphenyl)alanine, EINECS 200-445-2, dihydroxyphenylalanine, NSC 118381, L-3,4-Dihydrophenylalanine, L-.beta.-(3,4-Dihydroxyphenyl)alanine, CHEMBL1009, .beta.-(3,4-Dihydroxyphenyl)-L-alanine, beta-(3,4-Dihydroxyphenyl)-alpha-alanine, L-(3,4-Dihydroxyphenyl)alanine, CVT-301, WTDRDQBEARUVNC-LURJTMIESA-N, NSC118381, .beta.-(3,4-Dihydroxyphenyl)alanine, C9H11NO4, CAS-59-92-7, NCGC00016270-04, L-(3,4-Dihydroxyphenyl)-.alpha.-alanine, 46627O600J, 587-45-1, BDBM50130192, L Dopa, WLN: QVYZ1R CQ DQ, SR-01000075384, Dopastone, Dopicar, Inbrija, Prolopa, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate, IV Levodopa, Levodopa [USAN:INN:BAN:JAN], Prestwick_185, Levodopa (Sinemet), L-DOPA; Levodopa, Madopa (Salt/Mix), Levodopa [USAN:USP:INN:BAN:JAN], Spectrum_000454, AC1L1LOR, Prestwick0_000017, Prestwick1_000017, Prestwick2_000017, Prestwick3_000017, Spectrum2_000496, Spectrum4_000539, Spectrum5_001899, Lopac-D-9628, Levodopa (JP15/USP), DSSTox_CID_3209, bmse000322, D08HVR, Epitope ID:150927, AC1Q4U7F, 3, 4-Dihydroxyphenylalanine, Alanine,4-dihydroxyphenyl)-, DSSTox_RID_76926, DSSTox_GSID_23209, Lopac0_000454, SCHEMBL22655, BSPBio_000053, BSPBio_002354, KBioGR_001177, KBioSS_000934, L-4-5-Dihydroxyphenylalanine, MLS000028514, BIDD:GT0158, DivK1c_000452, L-Dopa, L-3-Hydroxytyrosine, SPECTRUM2300205, Levodopa (JP17/USP/INN), SPBio_000391, SPBio_001974, BPBio1_000059, GTPL3639, (S)-3,4-dihydroxyphenylalanine, b-(3,4-Dihydroxyphenyl)alanine, DTXSID9023209, WLN: QVYZ1R CQ DQ -L, 3, 4-Dihydroxy-L-phenylalanine, BDBM60928, CTK1H2187, HMS501G14, KBio1_000452, KBio2_000934, KBio2_003502, KBio2_006070, Alanine,4-dihydroxyphenyl)-, L-, L-(3, 4-Dihydroxyphenyl)alanine, MolPort-000-856-937, NINDS_000452, HMS1568C15, HMS1922J14, HMS2090O08, HMS2093N04, HMS2095C15, HMS2230B04, HMS3261K10, HMS3712C15, Pharmakon1600-02300205, ZINC895199, HY-N0304, b-(3,4-Dihydroxyphenyl)-L-alanine, Tox21_110338, Tox21_500454, ANW-33396, CCG-39571, KM0355, L-3-(3,4-dihydroxy-phenyl)alanine, L-3-(3,4-dihydroxyphenyl)-Alanine, LS-255, MFCD00002598, NSC759573, PDSP1_001541, PDSP2_001525, s1726, SBB017533, Alanine, 3-(3,4-dihydroxyphenyl)-, Alanine,4-dihydroxyphenyl)-, (-)-, AKOS010396267, b-(3,4-Dihydroxyphenyl)-a-L-alanine, L-b-(3,4-Dihydroxyphenyl)-a-alanine, .beta.-(3, 4-Dihydroxyphenyl)alanine, AC-8432, AM82124, AN-1108, CS-1945, DB01235, LP00454, MCULE-4743781842, NSC-118381, NSC-759573, RTR-020755, SDCCGMLS-0066924.P001, VA11170, IDI1_000452, NCGC00015384-01, NCGC00016270-01, NCGC00016270-06, NCGC00016270-07, NCGC00016270-09, NCGC00016270-10, NCGC00093869-04, NCGC00261139-01, AJ-24154, AS-13287, BC677906, BP-12850, H813, KB-28327, SC-10704, SMR000058312, ST086623, SBI-0050439.P003, AB0013279, AB1009504, L-(3, 4-Dihydroxyphenyl)-.alpha.-alanine, TR-020755, D0600, D9628, EU-0100454, FT-0603250, N1648, 59L927, Alanine, 3-(3, 4-dihydroxyphenyl)-, (-)-, C00355, D 9628, D00059, J10404, 13173-EP2269989A1, 13173-EP2277876A1, 13173-EP2277882A1, 13173-EP2281559A1, 13173-EP2281815A1, 13173-EP2292614A1, 13173-EP2295412A1, 13173-EP2295413A1, 13173-EP2295439A1, 13173-EP2298731A1, 13173-EP2301933A1, 13173-EP2301934A1, 13173-EP2305633A1, 13173-EP2305640A2, 13173-EP2308867A2, 13173-EP2308870A2, 13173-EP2311827A1, 13173-EP2311837A1, 13173-EP2314571A2, 13173-EP2316470A2, 13173-EP2316834A1, 21660-EP2272832A1, 21660-EP2275420A1, 21660-EP2281559A1, 21660-EP2301934A1, 21660-EP2314571A2, 21920-EP2295410A1, 21920-EP2301939A1, 21920-EP2314571A2, 3,4-Dihydroxy-L-phenylalanine, >=98% (TLC), AB00052418-06, AB00052418-07, AB00052418_08, AB00052418_09, Q-201294, SR-01000075384-1, SR-01000075384-4, SR-01000075384-6, SR-01000075384-7, I01-10387, Levodopa (optimized formulation, Parkinson's disease), More effective levodopa (Parkinson's disease), Orion, (S)-2-Amino-3-(3,4-dihydroxy-phenyl)-propionic acid, F0347-4695, Levodopa, British Pharmacopoeia (BP) Reference Standard, Levodopa, European Pharmacopoeia (EP) Reference Standard, Z1762772338, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acidL-dopa, UNII-QI9C343R60 component WTDRDQBEARUVNC-LURJTMIESA-N, 1E83F927-C221-46AA-B90A-81B33C5F3868, 3,4-Dihydroxy-L-phenylalanine, Vetec(TM) reagent grade, 98%, Levodopa (optimized formulation, Parkinson's disease), Orion, Levodopa, United States Pharmacopeia (USP) Reference Standard, L-3-(3,4-Dihydroxyphenyl)alanine（L-DOPA ）, 3-(3,4-Dihydroxyphenyl)-L-alanine; L-3-Hydroxytyrosine; L-DOPA; Levodopa, Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material, 23734-74-9, 25525-15-9, 34241-25-3, 72572-99-7, 72573-00-3, 88250-23-1, 90638-38-3, (2S)-2-ammonio-3-(3,4-dihydroxyphenyl)propanoate, (2S)-2-azaniumyl-3-(3,4-dihydroxyphenyl)propanoate, L-dopa zwitterion, L-dihydroxy-phenylalanine, AC1ODZ2Q, CHEBI:57504, ZB014991, A832543, (2S)-2-azaniumyl-3-[3,4-bis(oxidanyl)phenyl]propanoate